US Stock MarketDetailed Quotes
JNJ Johnson & Johnson
- 154.770
- +0.770+0.50%
Close Nov 18 16:00 ET
- 154.770
- 0.0000.00%
Post 20:02 ET
372.63BMarket Cap25.17P/E (TTM)
155.330High152.330Low7.51MVolume152.590Open154.000Pre Close1.16BTurnover0.31%Turnover Ratio11.28P/E (Static)2.41BShares168.85052wk High5.31P/B372.08BFloat Cap140.91152wk Low4.86Dividend TTM2.40BShs Float173.607Historical High3.14%Div YieldTTM1.95%Amplitude12.333Historical Low154.515Avg Price1Lot Size
About Johnson & Johnson Company
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Company Profile
SymbolJNJ
Company NameJohnson & Johnson
Listing DateSep 25, 1944
Founded1887
CEOMr. Joaquin Duato
MarketNYSE
Employees131900
Fiscal Year Ends12-31
AddressOne Johnson & Johnson Plaza
CityNew Brunswick
ProvinceNew Jersey
CountryUnited States of America
Zip Code08933
Phone1-732-524-0400
Websitehttp://www.jnj.com
Company Executives
- Name
- Position
- Salary
- Joaquin Duato
- Chairman of the Board and Chief Executive Officer
- 28.40M
- William N. Hait, M.D.,PhD
- Executive Vice President, Chief External Innovation and Medical Officer
- --
- Kathryn E. Wengel
- Executive Vice President and Chief Technical Operations & Risk Officer
- --
- Kristen Mulholland
- Chief Human Resources Officer
- --
- Robert J. Decker, Jr
- Controller and Chief Accounting Officer
- --
- Joseph J. Wolk, C.P.A.
- Executive Vice President and Chief Financial Officer
- 13.91M
- James D. Swanson
- Executive Vice President and Chief Information Officer
- --
- Jennifer L. Taubert
- Executive Vice President and Worldwide Chairman, Innovative Medicine
- 11.00M
- Elizabeth Forminard
- Executive Vice President and General Counsel
- --
- Dr. John C. Reed,M.D.,PhD
- Executive Vice President, Innovative Medicine, R&D
- 20.65M
- Vanessa Broadhurst
- Executive Vice President, Global Corporate Affairs
- --
- Timothy Schmid
- Executive Vice President and Worldwide Chairman, MedTech
- --
- Dr. Mary C. Beckerle, PhD
- Independent Director
- 355.00K
- Mark A. Weinberger
- Independent Director
- 340.00K
- Darius E. Adamczyk
- Independent Director
- 340.00K
- Eugene A. Woods
- Independent Director
- 89.15K
- Dr. Jennifer A. Doudna, PhD
- Independent Director
- 320.00K
- Marillyn A. Hewson
- Independent Director
- 360.00K
- Dr. Mark B. McClellan, M.D.,PhD
- Independent Director
- 320.00K
- Hubert Joly
- Independent Director
- 320.00K
- Dr. Nadja Y West, M.D.
- Independent Director
- 340.00K
- Anne M. Mulcahy
- Lead Independent Director
- 410.00K
- Dr. Paula A. Johnson,M.D.
- Independent Director
- 352.97K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
